Zenosense, Inc. (ZENO) and International Stem Cell Corp. (ISCO) Charting Success in the Healthcare Technology Markets
Healthcare technology companies Zenosense Inc. and International Stem Cell Corp. are laying significant groundwork with their proactive research in the areas of MRSA detection and the creation of pluripotent human stem cells from unfertilized oocytes (eggs). Zenosense is a detection device development company based in Valencia, Spain. Its mission is to develop, market and sell an effective MRSA detector, by way of licensed-in technology, for sale to healthcare providers for use in clinical settings. International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic…